Basic Information
Basic information for CPB2-AS1-211-20aa-2
Peptide Name CPB2-AS1-211-20aa-2
Genome Position chr13:46052848-46052907[+]
Species Human
Peptide Sequence MRAVRVRRDLEIESVLCERS
Peptide Length 20
Unique No (CPB2-AS1-201-20aa-1,CPB2-AS1-202-20aa-1,CPB2-AS1-203-20aa,CPB2-AS1-204-20aa-2,CPB2-AS1-205-20aa-1,CPB2-AS1-207-20aa-1,CPB2-AS1-208-20aa,CPB2-AS1-209-20aa,CPB2-AS1-212-20aa-1,CPB2-AS1-213-20aa-2,CPB2-AS1-215-20aa-1,CPB2-AS1-217-20aa,CPB2-AS1-218-20aa-2)
Grand Average of Hydropathicity -0.36
Relative Molecular Mass 2760.09
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235903;CPB2-AS1
Transcript ID/Name ENST00000663015;CPB2-AS1-211
Transcript Length 2164
Coding Ability 0.3623
DNA Sequence Corresponding to Peptide ATGCGAGCGGTAAGAGTGCGGCGGGACTTGGAAATCGAATCTGTGCTCTGTGAGAGATCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :